M. de las Heras

Risk-adapted adjuvant chemotherapy after concomitant fluoropyrimidine-radiotherapy neoadjuvant treatment for patients with resectable cT3-4 or N+ rectal cancer

E. Díaz-Rubio, J. Sastre, J. Puente, 2011, Anti-cancer drugs.

Clinical and technological transition in breast cancer.

H. Marsiglia, P. Poortmans, M. Algara, 2013, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

Prognostic Significance of Vascular Endothelial Growth Factor and Cyclooxygenase-2 in Patients with Rectal Cancer Treated with Preoperative Radiotherapy

L. Cerezo, S. Ramón y. Cajal, B. Navalpotro, 2007, Oncology.

Erlotinib and chemoradiation in patients with surgically resected locally advanced squamous cell carcinoma of the head and neck: a GICOR phase I trial.

J. García-Saenz, F. Calvo, V. Arrazubi, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Self-healing cutaneous mucinosis.

A. Ledo, M. de las Heras, J. Arrazola, 1996, Dermatology.

Prognostic value of ornithine decarboxylase and polyamines in human breast cancer: correlation with clinicopathologic parameters.

J. Díaz, M. de las Heras, J. Salinas, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

The expression of epidermal growth factor receptor results in a worse prognosis for patients with rectal cancer treated with preoperative radiotherapy: a multicenter, retrospective analysis.

L. Cerezo, J. Giralt, I. de Torres, 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Phase II study of radiochemotherapy with UFT and low-dose oral leucovorin in patients with unresectable rectal cancer.

R. Magallón, J. Tisaire, C. Regueiro, 1999, International journal of radiation oncology, biology, physics.

Long-term changes in pulmonary function after incidental lung irradiation for breast cancer: a prospective study with 7-year follow-up.

J. Pérez-Regadera, M. de las Heras, J. Jaén, 2012, International journal of radiation oncology, biology, physics.

Preoperative values of CA 15-3 and CEA as prognostic factors in breast cancer: a multivariate analysis.

M. de las Heras, J. Solà, J. Salinas, 2001, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[Burkitt's lymphoma: atypical localization].

M. Reus, M. de las Heras, R. Lencina, 1996, Revista Espanola de Enfermedades Digestivas.

Prognostic Significance of Vascular Endothelial Growth Factor and Cyclooxygenase-2 in Patients with Rectal Cancer Treated with Preoperative Radiotherapy

L. Cerezo, S. Ramón y. Cajal, B. Navalpotro, 2007, Oncology.